Overview

Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a study to investigate the pharmacokinetics of deferasirox
Phase:
Phase 1
Details
Lead Sponsor:
Novartis
Treatments:
Deferasirox
Midazolam